The FDA is holding a press conference to discuss the COVID-19 vaccine emergency approval
Show Transcript
D A. Authorized the Pfizer bio and tech vaccine for individuals over the age of 16. Although this is not an FDA approval, this authorization makes Pfizer bio and text vaccine available in the United States and holds the promise toe alter the course of this pandemic. It s a truly remarkable achievement of vaccine development made in less than a year s time, with science guiding our decision making the available safety and effectiveness data support the authorization of the Pfizer bio and tech vaccine because the vaccines known in potential benefits, outweigh its known a potential risks. The data provided by the sponsor have met the FDA is expectations conveyed in our June and October guidance documents. Efforts to speed vaccine development have not sacrificed scientific standards or the integrity of our vaccine evaluation process. In making our emergency use authorization determi